Neutrophilia and mortality in women with uterine carcinosarcoma.

Rebecca ArendAnne Van ArsdaleAnar GojayevBrandon Michael RoaneDavid DooCharles LeathGary L GoldbergGloria Shining Huang

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2019)

High pre-treatment absolute neutrophil count is an independent poor prognostic factor in patients with uterine carcinosarcoma and may be useful as a potential biomarker in clinical trials. The mechanistic relationship of neutrophilia and uterine carcinosarcoma progression merits further investigation.

Keyphrases

prognostic factors
clinical trial
cardiovascular events
risk factors
randomized controlled trial
peripheral blood
combination therapy
study protocol
replacement therapy